A multiplex technology platform for the rapid detection of relevant mutations in the EGFR signaling pathway.
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. Labourier, D. Smith, W. Laosinchai-Wolf, L. Friar, J. Houghton, A. Hadd, G. Latham
Institution: Asuragen (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2569969069
